Source: International Congress 2017 – Lung cancer immunotherapy



Rating:

Share or cite this content

Citations should be made in the following way:
Achim Rittmeyer (Immenhausen, Germany). Checkpointinhibition in lung cancer – already standard of care in any line of therapy? . International Congress 2017 – Lung cancer immunotherapy

Member's Comments

No comment yet.

Related content which might interest you: Palliative care or standard chemotherapy in lung cancer patients? Source: Annual Congress 2012 - Ethics Grand Round: an interactive session Year: 2012 Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care? Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 The role of palliative radiotherapy in locally advanced non small cell lung cancer Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Delays in lung cancer management Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Expressed wishes and incidence of euthanasia in advanced lung cancer patients}, Source: Eur Respir J 2012; 40: 949-956 Year: 2012 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT) Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 An educational intervention for lung cancer patients treated with chemotherapy: a first evaluation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 Perioperative systemic therapy in resectable lung cancer: from standard operating procedures to immuno-oncology and back Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 378s Year: 2001 Integration of palliative care from the very beginning to the very end in a patient with metastasised non-small cell lung cancer Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care Year: 2018 Defining a standard set of patient-centred outcomes for lung cancer Source: Eur Respir J 2016; 48: 852-860 Year: 2016 Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Source: Eur Respir J 2002; 19: 464-468 Year: 2002 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011 Palliative care specific for lung cancer Source: International Congress 2018 – Palliative care specific for respiratory diseases Year: 2018